Medical Colleges – vision mp | visionmp com visionmp.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from visionmp.com Daily Mail and Mail on Sunday newspapers.
Dr Varun Malhotra, Additional Professor, All India Institute of Medical Sciences (AIIMS), Bhopal, delivered an insightful talk at the "Meditation: Perception to Physiology" CME-cum-Workshop hosted by People s College of Medical Sciences & Research Centre (PCMS & RC), Bhopal.
The event was
Medical Colleges – vision mp | visionmp com visionmp.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from visionmp.com Daily Mail and Mail on Sunday newspapers.
Questions over India’s Covaxin side effects, ethical violations Quartz 1/12/2021
A shadow is lurking over the trial process of India’s homegrown Covid-19 vaccine.
Covaxin, the novel coronavirus vaccine co-developed by Bharat Biotech and the Indian Council for Medical Research, has been accused by some trial participants of sidestepping procedures and not making adverse events public. It has denied these charges, but trial volunteers want the government to intervene and halt the phase 3 human trials.
Bharat Biotech began courting controversy on On Jan. 4, when scientists expressed grave concerns over the hasty approval given to Covaxin. Now, its trial participants in Madhya Pradesh’s Bhopal allege that they were not informed that the jab would be given to them as part of a clinical trial. Covaxin’s third phase of human trials has 25,800 participants across the country.
Bhopal activists demand probe into Covaxin trials incident
January 11, 2021
Allege gross violation of laws governing clinical trials
As the country prepares to roll out two Covid-19 vaccines on a mass scale, a clutch of organisations from Bhopal have written to the Prime Minister and Health Minister on allegations of serious violations in the Phase-3 clinical trials being conducted at the People’s College of Medical Sciences & Research Centre in Bhopal to assess the safety, immunogenicity and efficacy of Covaxin.
Covaxin is the Covid-19 vaccine from Bharat Biotech being developed in collaboration with the Indian Council of Medical Research (ICMR). It was recently approved for restricted use, (along with Serum Institute of India’s vaccine), but in a clinical trial mode - a caveat that had many scientific voices raising concerns on its implications.